Immune Thrombocytopenia (ITP) Clinical Trials

A listing of Immune Thrombocytopenia (ITP) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 50 clinical trials
Featured trial
Eltrombopag Added to Standard Immunosuppression in Treatment-Naive Severe Aplastic Anemia

Background: Severe aplastic anemia is a rare and serious blood disorder. It happens when the immune system starts to attack the bone marrow cells. This causes the bone marrow to stop making red blood cells, platelets, and white blood cells. Standard treatment for this disease is horse-ATG and cyclosporine, which …

myelodysplastic syndrome (mds)
anemia
anemia studies
aplastic anemia
myelodysplastic syndromes
  • 132 views
  • 22 Dec, 2020
  • 1 location
None
A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

This is an open-label long-term multicenter phase 3 trial to evaluate the efficacy and safety of ARGX-113 in adult patients with primary ITP.

  • 0 views
  • 17 Nov, 2021
  • 130 locations
None
  • 17 views
  • 27 Nov, 2021
  • 66 locations
None
  • 0 views
  • 14 Nov, 2021
  • 73 locations
None
A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

Primary immune thrombocytopenia (ITP) is a rare disease that results in low levels of platelets - the cells that help blood clot. The main aim of the study is to check for side effects

  • 0 views
  • 30 Sep, 2021
  • 31 locations
None
Avatrombopag in Primary Immune Thrombocytopenia (ITP) in Adults

This single-center study aims to study the efficacy and safety of avatrombopag in Chinese adult ITP patients. This study will be conducted in adult ITP patients who had not responded to eltrombopag or rhTPO in the previous treatment .

  • 0 views
  • 28 May, 2021
  • 1 location
None
Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

This multicenter randomized, open-label study aimed to compare the efficacy and safety of eltrombopag combining rituximab with eltrombopag in China adult ITP patients .This study was be conducted in adult ITP patients who had not responded to or had relapsed after previous treatment of ITP, including first line therapy and …

  • 0 views
  • 25 Jan, 2021
  • 1 location
None
Study to Evaluate the Efficacy and Safety of PANZYGA in Pediatric Patients With Chronic Immune Thrombocytopenia (ITP)

This is a prospective, open-label, single-arm, multicenter, Phase 4 study evaluating the efficacy and safety of PANZYGA in pediatric patients with chronic ITP.

  • 0 views
  • 13 Nov, 2021
  • 8 locations
None
Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura

This study is designed to evaluate the efficacy and safety of single agent Doxil in the treatment of patients with refractory ITP (Idiopathic Thrombocytopenic Purpura).

thrombocytopenia
platelet count
immune globulin
purpura
immunoglobulins
  • 161 views
  • 07 Nov, 2020
  • 1 location
None
Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITP

Primary immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with low platelet count. As the first choice of the second-line treatment of ITP, thrombopoietin receptor agonist (TPO-RA

platelet count
eltrombopag
  • 1 views
  • 19 Jun, 2021
  • 1 location